|    Join     |    Donate    |   Store    |   About NAMS
Facebook TwitterYouTubeGoogle +RSS

What Selective Estrogen Receptor Modulators (SERMs) Can Do for You

Selective estrogen receptor modulators (SERMs) are big words for a revolutionary idea. These drugs can be extremely helpful for women who have specific health concerns about hormone therapy but need relief from hot flashes, low bone mineral density, vaginal atrophy, and bleeding. There are also SERMs available for women with a history or family history of breast cancer. SERMs activate or block the estrogen receptors only in certain areas of the body and not others. That can make them safer than estrogen alone or result in fewer side effects.

Discussion About SERMs With the Experts

This informative video is hosted by NAMS Board of Trustees Member and President-Elect Dr. Marla Shapiro.   Dr. Shapiro is also the medical consultant for CTV News and on-air medical contributor to Canada AM. In this video, Dr. Shapiro interviews Dr. JoAnn Pinkerton, NAMS Executive Director and Professor of Obstetrics and Gynecology and Director of Midlife Health at the University of Virginia Health System in Charlottesville, about what SERMs are and how they can help women.


 

Frequently Asked Questions About SERMs

Get answers to the 12 most-frequently asked questions about SERMs.

SERM FAQs


NAMS is grateful to Pfizer Inc. for its unrestricted educational grant funding that helped support the development of this education project.

SERMs Education Task Force

James H. Liu, MD, NCMP—Team Leader

Treasurer, The North American Menopause Society
Arthur H. Bill Professor and Chair
Department of Obstetrics and Gynecology
University Hospitals Case Medical Center
MacDonald Women’s Hospital
Department of Reproductive Biology
Case Western Reserve University School of Medicine
Cleveland, OH
Dr. Liu reports Consultant/Advisory Board or Honoraria: Actavis, Charter Venture, Nuelle, Sermonix; Grants to the institution from AbbVie, Actavis, Agile, Ferring, Palatin, and Pharmacos.

David F. Archer, MD, NCMP

Director, Intramural Clinical Research Center Force, CONRAD
Director, Clinical Research Center, Jones Institute for Reproductive Medicine
Professor, Department of Obstetrics and Gynecology
Eastern Virginia Medical School
Norfolk, VA
Dr. Archer reports Consultant/Advisory Board or Review Panel: AbbVie, Agile Pharmaceuticals, Bayer Healthcare, EndoCeutics, Exetis/CHEMO France, TherapeuticsMD, Teva/HR Pharma; Grants to the institution from AbbVie, Bayer Healthcare, EndoCeutics, and TherapeuticsMD.

JoAnn V. Pinkerton, MD, NCMP

Executive Director, The North American Menopause Society (NAMS)
Professor of Obstetrics and Gynecology and Division Director of Midlife Health
The University of Virginia Health System
Charlottesville, VA
Dr. Pinkerton reports Royalties: Henry Stewart Publications; Consultant/Advisory Board (fee to UVA): Pfizer; Grant/Research Support (fee to UVA): TherapeuticsMD

Gloria Richard-Davis, MD

Secretary, The North American Menopause Society
Division Director
Reproductive Endocrinology and Infertility
University of Arkansas Medical Sciences
Department of Obstetrics and Gynecology
Little Rock, AR
Dr. RichardDavis reports Consultant/Advisory Board: Pfizer

Nanette F. Santoro, MD

Board Member, The North American Menopause Society
Professor and E. Stewart Taylor Chair of Obstetrics and Gynecology
University of Colorado School of Medicine
Aurora, CO
Dr. Santoro reports Grant/Research Support: Bayer, Inc.; Stock/Ownership: Menogenix

Copyright© 2017 |  Home  |  Privacy Policy  |   Site Map |

 

30100 Chagrin Blvd, Suite 210 - Pepper Pike, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 8 + 1.